CVE-2017-12285

Description

A vulnerability in the web interface of Cisco Network Analysis Module Software could allow an unauthenticated, remote attacker to delete arbitrary files from an affected system, aka Directory Traversal. The vulnerability exists because the affected software does not perform proper input validation of HTTP requests that it receives and the software does not apply role-based access controls (RBACs) to requested HTTP URLs. An attacker could exploit this vulnerability by sending a crafted HTTP request to the affected software. A successful exploit could allow the attacker to delete arbitrary files from the affected system. Cisco Bug IDs: CSCvf41365.

Category

5.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 77.45% Top 5%
Vendor Advisory cisco.com
Affected: n/a Cisco Network Analysis Module
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2017-12285?
CVE-2017-12285 has been scored as a medium severity vulnerability.
How to fix CVE-2017-12285?
To fix CVE-2017-12285, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-12285 being actively exploited in the wild?
It is possible that CVE-2017-12285 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~77% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-12285?
CVE-2017-12285 affects n/a Cisco Network Analysis Module.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.